Insights into the Assessment of Measurable Residual Disease (MRD) in Patients With Multiple Myeloma

被引：0
|
作者：
Costa, Luciano J. [1 ,2 ,3 ]
机构：
[1] Univ Alabama Birmingham, Sch Med, Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Sch Med, ONeal Comprehens Canc Ctr Clin Trials Off, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Sch Med, Hematol Malignancies Working Grp, Hematol & Oncol, Birmingham, AL 35294 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：11 / 16
页数：6
相关论文
共 50 条
  • [21] Measurable Residual Disease (MRD): Is it a Thing in AML?
    Ossenkoppele, Gert
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S59 - S60
  • [22] Clinical implications of measurable residual disease assessment in multiple myeloma in the era of quadruplet therapy
    Bal, Susan
    Schmidt, Timothy M.
    Costa, Luciano J.
    Callander, Natalie S.
    LEUKEMIA & LYMPHOMA, 2022, 63 (14) : 3288 - 3298
  • [23] Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP)
    Derman, Benjamin Avi
    Cooperrider, Jennifer H.
    Kubicki, Tadeusz
    Major, Ajay
    Jiang, Ken
    Ramsland, Aubrianna
    Buckley, Karson
    Melka, Samrawit
    McIver, Amanda
    Karrison, Theodore
    Jakubowiak, Andrzej J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP)
    Derman, Benjamin A.
    Major, Ajay
    Cooperrider, Jennifer
    Jiang, Ken
    Ramsland, Aubrianna
    Karrison, Theodore
    Kubicki, Tadeusz
    Jakubowiak, Andrzej J.
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [25] Multiomics Profiling of Measurable Residual Disease (MRD) for Understanding the Biology of Ultra-Drug Resistance in Multiple Myeloma (MM)
    Guerrero, Camila
    Puig, Noemi
    Cedena Romero, Maria Teresa
    Goicoechea, Ibai
    Burgos, Leire
    Alignani, Diego
    Lopez, Aitziber
    Sarvide, Sarai
    Jose Calasanz, Maria
    Garcia-Sanz, Ramon
    Martinez-Lopez, Joaquin
    Rosinol, Laura
    Gonzalez Garcia, Esther
    Oriol, Albert
    Rios, Rafael
    Carrillo-Cruz, Estrella
    Gonzalez Perez, Marta Sonia
    Montes Gaisan, Carmen
    De Arriba, Felipe
    Maria Arguinano, Jose
    Marti, Josep M.
    Gonzalez-Montes, Yolanda
    Garcia-Guinon, Antonio
    Lahuerta, Juan-Jose
    Blade Creixenti, Joan
    Mateos, Maria-Victoria
    San-Miguel, Jesus
    Paiva, Bruno
    BLOOD, 2022, 140
  • [26] Measurable residual disease in multiple myeloma: ready for clinical practice?
    Leire Burgos
    Noemi Puig
    Maria-Teresa Cedena
    María-Victoria Mateos
    Juan José Lahuerta
    Bruno Paiva
    Jesús F. San-Miguel
    Journal of Hematology & Oncology, 13
  • [27] The Relevance of Minimal Residual Disease (MRD) Monitoring in Elderly Multiple Myeloma (MM) Patients
    Paiva, Bruno
    Cedena, Teresa
    Puig, Noemi
    Cordon, Lourdes
    Martinez-Lopez, Joaquin
    Ocio, Enrique M.
    Hernandez, Miguel T.
    Isabel Teruel, Ana
    Gironella, Mercedes
    Asuncion Echeveste, M.
    Rosinol, Laura
    Martinez, Rafael
    Oriol, Albert
    Martin, Jesus
    Gutierrez, Norma C.
    Belen Vidriales, Maria
    Blade, Joan
    Jose Lahuerta, Juan
    Mateos, Maria-Victoria
    San Miguel, Jesus
    BLOOD, 2015, 126 (23)
  • [28] Measurable Residual Disease and Decision-Making in Multiple Myeloma
    Derman, Benjamin A.
    Fonseca, Rafael
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (02) : 477 - 495
  • [29] Measurable residual disease in multiple myeloma: ready for clinical practice?
    Burgos, Leire
    Puig, Noemi
    Cedena, Maria-Teresa
    Mateos, Maria-Victoria
    Lahuerta, Juan Jose
    Paiva, Bruno
    San-Miguel, Jesus F.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [30] Assessment of Measurable Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Among US Community Hematologists/ Oncologists (cH/O)
    Gajra, Ajeet
    Rathish, Yamini S.
    Jeune-Smith, Yolaine
    Klink, Andrew J.
    Feinberg, Bruce
    BLOOD, 2020, 136
12345